These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
300 related items for PubMed ID: 7687537
1. Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src. Superti-Furga G, Fumagalli S, Koegl M, Courtneidge SA, Draetta G. EMBO J; 1993 Jul; 12(7):2625-34. PubMed ID: 7687537 [Abstract] [Full Text] [Related]
2. Csk suppression of Src involves movement of Csk to sites of Src activity. Howell BW, Cooper JA. Mol Cell Biol; 1994 Aug; 14(8):5402-11. PubMed ID: 7518562 [Abstract] [Full Text] [Related]
6. Mutational analysis of the Src SH3 domain: the same residues of the ligand binding surface are important for intra- and intermolecular interactions. Erpel T, Superti-Furga G, Courtneidge SA. EMBO J; 1995 Mar 01; 14(5):963-75. PubMed ID: 7534229 [Abstract] [Full Text] [Related]
8. Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src. Sabe H, Hata A, Okada M, Nakagawa H, Hanafusa H. Proc Natl Acad Sci U S A; 1994 Apr 26; 91(9):3984-8. PubMed ID: 7513429 [Abstract] [Full Text] [Related]
9. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK. Cheng HC, Bjorge JD, Aebersold R, Fujita DJ, Wang JH. Biochemistry; 1996 Sep 10; 35(36):11874-87. PubMed ID: 8794770 [Abstract] [Full Text] [Related]
10. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation. Ayrapetov MK, Nam NH, Ye G, Kumar A, Parang K, Sun G. J Biol Chem; 2005 Jul 08; 280(27):25780-7. PubMed ID: 15890649 [Abstract] [Full Text] [Related]
11. Regulation of c-Src tyrosine kinase activity by the Src SH2 domain. Liu X, Brodeur SR, Gish G, Songyang Z, Cantley LC, Laudano AP, Pawson T. Oncogene; 1993 May 08; 8(5):1119-26. PubMed ID: 7683128 [Abstract] [Full Text] [Related]
15. Characterization of two activated mutants of human pp60c-src that escape c-Src kinase regulation by distinct mechanisms. Bjorge JD, Bellagamba C, Cheng HC, Tanaka A, Wang JH, Fujita DJ. J Biol Chem; 1995 Oct 13; 270(41):24222-8. PubMed ID: 7592628 [Abstract] [Full Text] [Related]
16. Structure of the carboxyl-terminal Src kinase, Csk. Ogawa A, Takayama Y, Sakai H, Chong KT, Takeuchi S, Nakagawa A, Nada S, Okada M, Tsukihara T. J Biol Chem; 2002 Apr 26; 277(17):14351-4. PubMed ID: 11884384 [Abstract] [Full Text] [Related]
17. Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis. Shekhtman A, Ghose R, Wang D, Cole PA, Cowburn D. J Mol Biol; 2001 Nov 16; 314(1):129-38. PubMed ID: 11724538 [Abstract] [Full Text] [Related]
19. Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation. Young MA, Gonfloni S, Superti-Furga G, Roux B, Kuriyan J. Cell; 2001 Apr 06; 105(1):115-26. PubMed ID: 11301007 [Abstract] [Full Text] [Related]
20. Structure of the regulatory domains of the Src-family tyrosine kinase Lck. Eck MJ, Atwell SK, Shoelson SE, Harrison SC. Nature; 1994 Apr 21; 368(6473):764-9. PubMed ID: 7512222 [Abstract] [Full Text] [Related] Page: [Next] [New Search]